Protea Biosciences Group (PRGBQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 2,447 | 1,862 | 1,768 | 1,224 | 834 |
| Cost of Goods | 1,706 | 741 | 872 | 933 | N/A |
| Gross Profit | 741 | 1,121 | 896 | 291 | 834 |
| Operating Expenses | 6,940 | 9,002 | 12,462 | 11,548 | 9,815 |
| Operating Income | -5,493 | -7,140 | -10,693 | -10,325 | -8,980 |
| Interest Expense | 1,968 | 1,617 | 745 | 746 | 542 |
| Other Income | -8,187 | -817 | -36 | -347 | -9 |
| Pre-tax Income | -15,648 | -9,574 | -11,475 | -11,418 | -9,531 |
| Net Income Continuous | -15,648 | -9,574 | -11,475 | -11,418 | -9,531 |
| Net Income | $-15,648 | $-9,574 | $-11,475 | $-11,418 | $-9,531 |
| EPS Basic Total Ops | -6.00 | -4.50 | -8.50 | -12.50 | -16.50 |
| EPS Basic Continuous Ops | -5.75 | -4.36 | -8.47 | -12.67 | -16.46 |
| EPS Diluted Total Ops | -6.00 | -4.50 | -8.50 | -12.50 | -16.50 |
| EPS Diluted Continuous Ops | -5.75 | -4.36 | -8.47 | -12.67 | -16.46 |
| EPS Diluted Before Non-Recurring Items | -2.50 | -4.50 | N/A | N/A | N/A |
| EBITDA(a) | $-4,815 | $-6,453 | $-9,867 | $-9,480 | $-7,971 |